A detailed history of Monetta Financial Services Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Monetta Financial Services Inc holds 10,000 shares of GILD stock, worth $897,600. This represents 0.71% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$897,600
% of portfolio
0.71%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$66.59 - $83.99 $665,900 - $839,900
10,000 New
10,000 $838,000
Q4 2023

Feb 08, 2024

BUY
$73.27 - $83.09 $769,335 - $872,445
10,500 New
10,500 $850,000
Q1 2022

May 09, 2022

SELL
$57.92 - $72.58 $637,120 - $798,380
-11,000 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$64.88 - $73.64 $713,680 - $810,040
11,000 New
11,000 $799,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Monetta Financial Services Inc Portfolio

Follow Monetta Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monetta Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monetta Financial Services Inc with notifications on news.